ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

An engineered antibody-lectin conjugate targeting the HIV glycan shield protects humanized mice against HIV challenge.

Rashmi Kumariya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.